---
title: "Colchicine linked to lower all-cause mortality in patients with diabetic gout without prior CAD"
id: "pubmed-43013613"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43013613"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43013613/"
doi: "10.1371/journal.pone.0362218"
published_at: "2026-11-11T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Colchicine linked to lower all-cause mortality in patients with diabetic gout without prior CAD
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43013613
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43013613/)
- **DOI:** [10.1371/journal.pone.0362218](https://doi.org/10.1371%2Fjournal.pone.0362218)
- **Published At:** 2026-11-11T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The investigators used the Korean National Health Insurance Service database to identify patients with **type 2 diabetes mellitus** and **gout** who had no prior coronary artery disease; the cohort spanned 2015–2019. - The initial cohort included 48,295 eligible patients; 28,964 were recorded as **colchicine** users and 19,331 as non-users before matching. - The study team performed 1:1 propensity score matching and produced 17,337 matched pairs for outcome comparisons. - The predefined primary outcome was a composite of **all-cause death**, nonfatal myocardial infarction, and nonfatal stroke. - The composite outcome occurred in 12.52% of colchicine users versus 15.03% of non-users; investigators reported a hazard ratio (HR) 0.71 (95% CI 0.66–0.75; P < 0.001). - **All-cause mortality** alone was lower in colchicine users: 8.01% versus 11.07% in non-users (HR 0.58; 95% CI 0.53–0.62; P < 0.001). - No statistically significant differences were found for nonfatal myocardial infarction (HR 1.15; 95% CI 0.96–1.37; P = 0.121) or nonfatal stroke (HR 0.91; 95% CI 0.81–1.01; P = 0.076). - The authors conducted a 365-day landmark analysis to address immortal time bias; associations with reduced all-cause mortality (HR 0.67; 95% CI 0.62–0.73; P < 0.001) and the composite outcome (HR 0.76; 95% CI 0.71–0.81; P < 0.001) persisted. - In the landmark analysis, myocardial infarction (HR 1.15; 95% CI 0.95–1.40; P = 0.144) and stroke (HR 0.99; 95% CI 0.87–1.12; P = 0.823) did not differ between groups. - The study authors concluded that the reduction in the composite outcome was driven by lower mortality rather than reductions in myocardial infarction or stroke. - The source did not report details on dosing regimens, duration of colchicine exposure, or safety/adverse event profiles in the abstract; those specifics were not available in the provided source text.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43013613/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43013613%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43013613/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43013613/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43013613/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43013613/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43013613/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43013613%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43013613%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43013613/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43013613/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43013613/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43013613/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43013613/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43013613/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43013613/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/43013613/#conflict-of-interest) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43013613/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/43013613/#substances) Title & authors Abstract Conflict of interest statement MeSH terms Substances PLoS One Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS+One%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS+One%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) . 2026 Nov 11;21(11):e0362218. doi: 10.1371/journal.pone.0362218. eCollection 2026. # Colchicine use was associated with reduced all-cause mortality in patients with diabetic gout without prior coronary artery disease: A propensity-matched nationwide cohort study [Yonghoon Shin](https://pubmed.ncbi.nlm.nih.gov/?term=Shin+Y&cauthor_id=43013613)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#full-view-affiliation-1 "Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea."), [Jung-Joon Cha](https://pubmed.ncbi.nlm.nih.gov/?term=Cha+JJ&cauthor_id=43013613)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#full-view-affiliation-1 "Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea."), [Ju Hyeon Kim](https://pubmed.ncbi.nlm.nih.gov/?term=Kim+JH&cauthor_id=43013613)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#full-view-affiliation-2 "Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea."), [Hyung Joon Joo](https://pubmed.ncbi.nlm.nih.gov/?term=Joo+HJ&cauthor_id=43013613)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#full-view-affiliation-1 "Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea."), [Jae Hyoung Park](https://pubmed.ncbi.nlm.nih.gov/?term=Park+JH&cauthor_id=43013613)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#full-view-affiliation-1 "Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea."), [Cheol Woong Yu](https://pubmed.ncbi.nlm.nih.gov/?term=Yu+CW&cauthor_id=43013613)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#full-view-affiliation-1 "Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea."), [Minae Park](https://pubmed.ncbi.nlm.nih.gov/?term=Park+M&cauthor_id=43013613)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#full-view-affiliation-3 "Department of Data Science, Hanmi Pharm. Co., Ltd, Seoul, South Korea."), [Yujin Lee](https://pubmed.ncbi.nlm.nih.gov/?term=Lee+Y&cauthor_id=43013613)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#full-view-affiliation-3 "Department of Data Science, Hanmi Pharm. Co., Ltd, Seoul, South Korea."), [Soon Jun Hong](https://pubmed.ncbi.nlm.nih.gov/?term=Hong+SJ&cauthor_id=43013613)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#full-view-affiliation-1 "Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.") Affiliations Expand ### Affiliations * 1 Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea. * 2 Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. * 3 Department of Data Science, Hanmi Pharm. Co., Ltd, Seoul, South Korea. * PMID: **43013613** * DOI: [ 10.1371/journal.pone.0362218 ](https://doi.org/10.1371/journal.pone.0362218) Item in Clipboard # Colchicine use was associated with reduced all-cause mortality in patients with diabetic gout without prior coronary artery disease: A propensity-matched nationwide cohort study Yonghoon Shin et al. PLoS One. 2026. Show details Display options Display options Format Abstract PubMed PMID PLoS One Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS+One%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS+One%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) . 2026 Nov 11;21(11):e0362218. doi: 10.1371/journal.pone.0362218. eCollection 2026. ### Authors [Yonghoon Shin](https://pubmed.ncbi.nlm.nih.gov/?term=Shin+Y&cauthor_id=43013613)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#short-view-affiliation-1 "Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea."), [Jung-Joon Cha](https://pubmed.ncbi.nlm.nih.gov/?term=Cha+JJ&cauthor_id=43013613)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#short-view-affiliation-1 "Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea."), [Ju Hyeon Kim](https://pubmed.ncbi.nlm.nih.gov/?term=Kim+JH&cauthor_id=43013613)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#short-view-affiliation-2 "Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea."), [Hyung Joon Joo](https://pubmed.ncbi.nlm.nih.gov/?term=Joo+HJ&cauthor_id=43013613)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#short-view-affiliation-1 "Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea."), [Jae Hyoung Park](https://pubmed.ncbi.nlm.nih.gov/?term=Park+JH&cauthor_id=43013613)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#short-view-affiliation-1 "Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea."), [Cheol Woong Yu](https://pubmed.ncbi.nlm.nih.gov/?term=Yu+CW&cauthor_id=43013613)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#short-view-affiliation-1 "Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea."), [Minae Park](https://pubmed.ncbi.nlm.nih.gov/?term=Park+M&cauthor_id=43013613)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#short-view-affiliation-3 "Department of Data Science, Hanmi Pharm. Co., Ltd, Seoul, South Korea."), [Yujin Lee](https://pubmed.ncbi.nlm.nih.gov/?term=Lee+Y&cauthor_id=43013613)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#short-view-affiliation-3 "Department of Data Science, Hanmi Pharm. Co., Ltd, Seoul, South Korea."), [Soon Jun Hong](https://pubmed.ncbi.nlm.nih.gov/?term=Hong+SJ&cauthor_id=43013613)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43013613/#short-view-affiliation-1 "Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.") ### Affiliations * 1 Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea. * 2 Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. * 3 Department of Data Science, Hanmi Pharm. Co., Ltd, Seoul, South Korea. * PMID: **43013613** * DOI: [ 10.1371/journal.pone.0362218 ](https://doi.org/10.1371/journal.pone.0362218) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Colchicine has been associated with reduced cardiovascular events in secondary prevention, but evidence for primary prevention is limited. We examined the association between colchicine use and cardiovascular outcomes in patients with type 2 diabetes mellitus and gout without prior coronary artery disease. From the Korean National Health Insurance Service database, we identified 48,295 patients with diabetes and gout without prior coronary artery disease between 2015 and 2019. We compared 28,964 colchicine users with 19,331 non-users by 1:1 propensity score matching, which produced 17,337 matched pairs. The primary outcome was a composite of all-cause death, nonfatal myocardial infarction, and nonfatal stroke. The primary composite outcome occurred in 12.52% of colchicine users versus 15.03% of non-users (hazard ratio [HR] 0.71; 95% confidence interval [CI] 0.66-0.75; P < 0.001). All-cause mortality was significantly reduced in colchicine users (8.01% vs. 11.07%; HR 0.58; 95% CI 0.53-0.62; P < 0.001). No significant differences were observed for myocardial infarction (HR 1.15; 95% CI 0.96-1.37; P = 0.121) or stroke (HR 0.91; 95% CI 0.81-1.01; P = 0.076). In a landmark analysis at 365 days that addressed immortal time bias, the associations with all-cause mortality (HR 0.67; 95% CI 0.62-0.73; P < 0.001) and with the composite outcome (HR 0.76; 95% CI 0.71-0.81; P < 0.001) remained significant, whereas stroke (HR 0.99; 95% CI 0.87-1.12; P = 0.823) and myocardial infarction (HR 1.15; 95% CI 0.95-1.40; P = 0.144) did not differ between the two groups. In patients with diabetes and gout without prior coronary artery disease, colchicine use was associated with lower all-cause mortality. The reduction in the composite outcome was driven by mortality rather than by myocardial infarction or stroke. Copyright: © 2026 Shin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement The authors have declared that no competing interests exist. ## MeSH terms * Aged Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Aged%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Aged) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * Cause of Death Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cause+of+Death%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cause+of+Death) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * Cohort Studies Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cohort+Studies%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cohort+Studies) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * Colchicine* / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Colchicine%2Ftherapeutic+use%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Colchicine) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * Coronary Artery Disease Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Coronary+Artery+Disease%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Coronary+Artery+Disease) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * Diabetes Mellitus, Type 2* / complications Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fcomplications%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * Diabetes Mellitus, Type 2* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * Diabetes Mellitus, Type 2* / mortality Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Diabetes+Mellitus%2C+Type+2%2Fmortality%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Diabetes+Mellitus%2C+Type+2) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * Female Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Female%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Female) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * Gout Suppressants* / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gout+Suppressants%2Ftherapeutic+use%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Gout+Suppressants) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * Gout* / complications Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gout%2Fcomplications%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Gout) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * Gout* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gout%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Gout) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * Gout* / mortality Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gout%2Fmortality%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Gout) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43013613/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search
## Related Clinical Research

- [Cardiovascular outcomes of GLP-1 receptor agonists: systematic review findings](https://medichelpline.com/clinical-feed/pubmed-42033237.md) (DOI: 10.1093/ajhp/zxag121)
- [Elevated Lipoprotein(a) Predicts Recurrent Myocardial Infarction After ACS in Patients with Diabet](https://medichelpline.com/clinical-feed/pubmed-42965402.md) (DOI: 10.1002/clc.70480)
- [Lp(a) HORIZON: Pelacarsen cut Lp(a) 78% but did not change cardiovascular events](https://medichelpline.com/clinical-feed/aha-news-0-lp-a-horizon-trial-lp-a-fell-by-78-but-cardiovascular-outcomes-unexpectedly.md)
- [Comparing BMI, Waist Circumference, and BRI for Predicting ASCVD, AF, and Mortality in 1.2M Koreans](https://medichelpline.com/clinical-feed/plos-one-14-prognostic-associations-of-anthropometric-indices-with-major-health-outcomes-a.md)
- [Participation in a low‑intensity health assessment program linked to lower diabetes risk in older](https://medichelpline.com/clinical-feed/plos-medicine-0-association-of-a-multiple-risk-factor-assessment-and-intervention-program-with.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.